Brainsway (BWAY) Long-Term Deferred Tax (2021 - 2025)
Brainsway (BWAY) posted quarterly Long-Term Deferred Tax of $2.7 million for Q4 2025, up 146.83% year-on-year from $1.1 million in Q4 2024, and up 146.83% on a QoQ basis from $1.1 million in Q4 2024.
Brainsway (BWAY) Long-Term Deferred Tax (2021 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Long-Term Deferred Tax for 5 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Deferred Tax rose 146.83% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 146.83% YoY) and the FY2025 annual result came in at $2.7 million, up 146.83% from the prior year.
- Long-Term Deferred Tax grew to $2.7 million in Q4 2025 per BWAY's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for BWAY reached as high as $2.7 million in Q4 2025 and fell as low as $334000.0 in Q4 2022.
- A 5-year average of $1.1 million and a median of $871000.0 in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax declined 27.07% — and 2023, when it jumped 160.78%.
- Year by year, Long-Term Deferred Tax stood at $458000.0 in 2021, then declined by 27.07% to $334000.0 in 2022, then surged by 160.78% to $871000.0 in 2023, then climbed by 23.31% to $1.1 million in 2024, then jumped by 146.83% to $2.7 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $2.7 million, $1.1 million, and $871000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 871,000.00 |
| Dec 31, 2022 | 334,000.00 |
| Dec 31, 2021 | 458,000.00 |